Raymond James & Associates Pacific Biosciences Of California, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 118,197 shares of PACB stock, worth $271,853. This represents 0.0% of its overall portfolio holdings.

Number of Shares

118,197

Previous 109,767 7.68%

Holding current value

$271,853

Previous $150,000 33.33%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$1.2 - $2.17 $10,116 - $18,293	8,430 Added 7.68%	118,197 $200,000
Q2 2024 Jul 19, 2024	BUY	$1.36 - $3.65 $31,498 - $84,537	23,161 Added 26.74%	109,767 $150,000
Q1 2024 Apr 22, 2024	BUY	$3.52 - $9.59 $67,629 - $184,252	19,213 Added 28.51%	86,606 $324,000
Q4 2023 Jan 16, 2024	BUY	$5.97 - $10.36 $73,866 - $128,184	12,373 Added 22.49%	67,393 $661,000
Q3 2023 Oct 24, 2023	SELL	$8.23 - $13.93 $154,114 - $260,853	-18,726 Reduced 25.39%	55,020 $459,000
Q2 2023 Jul 25, 2023	SELL	$9.97 - $14.05 $46,220 - $65,135	-4,636 Reduced 5.91%	73,746 $980,000
Q1 2023 Apr 14, 2023	SELL	$7.94 - $12.02 $56,199 - $85,077	-7,078 Reduced 8.28%	78,382 $907,000
Q4 2022 Feb 08, 2023	SELL	$5.67 - $11.2 $54,602 - $107,856	-9,630 Reduced 10.13%	85,460 $699,000
Q3 2022 Oct 25, 2022	BUY	$3.93 - $8.57 $5,364 - $11,698	1,365 Added 1.46%	95,090 $552,000
Q2 2022 Aug 12, 2022	SELL	$4.02 - $10.43 $72,203 - $187,333	-17,961 Reduced 16.08%	93,725 $414,000
Q1 2022 May 11, 2022	BUY	$8.43 - $20.9 $6,853 - $16,991	813 Added 0.73%	111,686 $1.02 Million
Q4 2021 Feb 08, 2022	SELL	$19.26 - $30.08 $429,498 - $670,784	-22,300 Reduced 16.75%	110,873 $2.27 Million
Q3 2021 Nov 02, 2021	BUY	$24.86 - $35.02 $79,900 - $112,554	3,214 Added 2.47%	133,173 $3.4 Million
Q2 2021 Aug 11, 2021	SELL	$22.3 - $36.02 $437,303 - $706,352	-19,610 Reduced 13.11%	129,959 $4.55 Million
Q1 2021 May 14, 2021	BUY	$26.38 - $51.15 $1.23 Million - $2.39 Million	46,782 Added 45.51%	149,569 $4.98 Million
Q4 2020 Feb 12, 2021	SELL	$10.5 - $28.5 $210,189 - $570,513	-20,018 Reduced 16.3%	102,787 $2.67 Million
Q3 2020 Nov 04, 2020	BUY	$3.61 - $9.87 $268,562 - $734,268	74,394 Added 153.67%	122,805 $1.21 Million
Q2 2020 Jul 28, 2020	BUY	$2.65 - $4.03 $128,289 - $195,096	48,411 New	48,411 $167,000
Q4 2019 Feb 12, 2020	SELL	$4.6 - $5.57 $55,199 - $66,840	-12,000 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$6.8 - $7.4 $81,600 - $88,800	12,000 New	12,000 $87,000

Others Institutions Holding PACB

# of Institutions

252

Shares Held

230M

Call Options Held

971K

Put Options Held

965K

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $517M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Pacific Biosciences Of California, Inc. Transaction History